OLAPARIB vs OLMESARTAN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
OLAPARIB vs OLMESARTAN: Safety Overview
| Metric | OLAPARIB | OLMESARTAN |
|---|---|---|
| Total FAERS Reports | 18,274 | 2,228 |
| Deaths Reported | 5,496 | 77 |
| Death Rate | 30.1% | 3.5% |
| Hospitalizations | 3,471 | 1,096 |
| Average Patient Age | 62.3 yrs | 68.9 yrs |
| % Female Patients | 79.9% | 52.8% |
| FDA Approval Date | Aug 17, 2017 | N/A |
| Manufacturer | AstraZeneca Pharmaceuticals LP | N/A |
| Route | ORAL | N/A |
| Marketing Status | Discontinued | N/A |